Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass
Abstract
Objectives: Assessment of additive impact of alfacalcidol 1
Further information:
Author: Felsenberg D, Bock O, Börst H, Armbrecht G, Beller G, Degner C, Stephan-Oelkers M, Schacht E, Mazor Z, Hashimoto J, Roth HJ, Martus P, Runge M
Organization: Center of Muscle and Bone Research, Charité - University Medicine Berlin, Campus Benjamin Franklin, Free University and Humboldt University Berlin, Berlin, Germany.
Year: 2011
- J Musculoskelet Neuronal Interact.
- 2011
- 11(1)
- 34-45
- PMID: 21364273
GID: 2587
Created on: 05.03.2011
